Regulus Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FEDERATED HERMES, INC. | 02/13/2025 | 12.85 M | $20.31 M | 0.00% | 19.63% |
NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 6.47 M | $10.22 M | 0.00% | 9.88% |
VIVO CAPITAL, LLC | 02/13/2025 | 5.00 M | $7.90 M | 0.00% | 7.64% |
OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 4.85 M | $7.66 M | 13.72% | 7.41% |
BLACKROCK, INC. | 02/07/2025 | 4.24 M | $6.69 M | 3.81% | 6.47% |
VANGUARD GROUP INC | 02/11/2025 | 3.97 M | $6.27 M | -2.98% | 6.06% |
DEEP TRACK CAPITAL, LP | 02/14/2025 | 3.26 M | $5.15 M | 0.00% | 4.98% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.19 M | $3.46 M | 69.75% | 3.35% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.00 M | $3.16 M | 0.00% | 3.05% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.28 M | $2.02 M | -0.10% | 1.95% |
STATE STREET CORP | 02/14/2025 | 1.06 M | $1.67 M | 5.54% | 1.61% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 1.04 M | $1.64 M | 0.00% | 1.58% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 895,128 | $1.41 M | 0.15% | 1.37% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 875,200 | $1.38 M | -2.23% | 1.34% |
NORTHERN TRUST CORP | 02/14/2025 | 457,233 | $722,428 | -8.06% | 0.70% |
VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 389,886 | $616,020 | -2.25% | 0.60% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 336,843 | $532,212 | -56.07% | 0.51% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 212,379 | $335,559 | 18.64% | 0.32% |
JPMORGAN CHASE & CO | 02/12/2025 | 190,457 | $300,922 | 141.17% | 0.29% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 178,879 | $282,629 | 0.00% | 0.27% |
CITADEL ADVISORS LLC | 02/14/2025 | 155,558 | $245,782 | 486,018.75% | 0.24% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 149,355 | $235,981 | 0.00% | 0.23% |
MORGAN STANLEY | 02/14/2025 | 139,791 | $220,870 | -16.83% | 0.21% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 117,100 | $185,018 | 20.47% | 0.18% |
TYCHE WEALTH PARTNERS LLC | 01/27/2025 | 106,089 | $167,621 | 0.00% | 0.16% |
BARCLAYS PLC | 02/13/2025 | 96,247 | $152,000 | 13.93% | 0.15% |
UBS GROUP AG | 02/14/2025 | 90,147 | $142,432 | 201.74% | 0.14% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 85,602 | $135,251 | 0.00% | 0.13% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 70,000 | $110,600 | 100.00% | 0.11% |
PEAK6 LLC | 02/13/2025 | 60,000 | $94,800 | 100.00% | 0.09% |
RHUMBLINE ADVISERS | 01/30/2025 | 59,531 | $94,052 | -20.09% | 0.09% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 53,841 | $85,068 | -1.08% | 0.08% |
CITIGROUP INC | 02/12/2025 | 50,138 | $79,218 | -6.69% | 0.08% |
LPL FINANCIAL LLC | 02/11/2025 | 49,980 | $78,968 | -13.80% | 0.08% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 49,400 | $78,000 | 0.00% | 0.08% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 36,701 | $57,988 | 4.40% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 36,188 | $57,177 | 100.00% | 0.06% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 35,159 | $55,551 | 32.25% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 31,397 | $49,607 | -7.02% | 0.05% |
INVESCO LTD. | 02/13/2025 | 30,248 | $47,792 | 7.06% | 0.05% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 29,597 | $47,000 | -98.62% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 28,480 | $44,998 | 100.00% | 0.04% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 26,880 | $42,470 | 0.00% | 0.04% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 23,074 | $36,457 | 0.00% | 0.04% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 22,264 | $35,177 | 16.07% | 0.03% |
PROSHARE ADVISORS LLC | 02/14/2025 | 17,785 | $28,099 | 49.05% | 0.03% |
CREATIVE PLANNING | 02/14/2025 | 14,116 | $22,303 | -14.27% | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 13,700 | $21,646 | -62.36% | 0.02% |
02/11/2025 | 12,696 | $20,060 | 100.00% | 0.02% | |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 11,700 | $18,000 | 1.74% | 0.02% |
Regulus Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 78 institutional investors and hedge funds held shares of Regulus Therapeutics Inc.. The most heavily invested institutionals were:
FEDERATED HERMES, INC.: 12.85 M
NEA Management Company, LLC: 6.47 M
Vivo Capital, LLC: 5 M
Octagon Capital Advisors LP: 4.85 M
BlackRock, Inc.: 4.24 M
VANGUARD GROUP INC: 3.97 M
81.73% of Regulus Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 57.90 M shares in the last 24 months. This purchase volume represents approximately $97.56 M in transactions.